25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BNTC (Benitec) Stock Analysis
Buy, Hold or Sell?

Let's analyze Benitec together

I guess you are interested in Benitec Biopharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Benitec’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Benitec’s Price Targets

I'm going to help you getting a better view of Benitec Biopharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.

1. Quick Overview

1.1. Quick analysis of Benitec (30 sec.)










1.2. What can you expect buying and holding a share of Benitec? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.66
Expected worth in 1 year
$3.04
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$1.37
Return On Investment
10.4%

For what price can you sell your share?

Current Price per Share
$13.17
Expected price per share
$9.7 - $16.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Benitec (5 min.)




Live pricePrice per Share (EOD)
$13.17
Intrinsic Value Per Share
$-4.18 - $-0.96
Total Value Per Share
$-2.51 - $0.70

2.2. Growth of Benitec (5 min.)




Is Benitec growing?

Current yearPrevious yearGrowGrow %
How rich?$64.1m$8.1m$38.6m82.6%

How much money is Benitec making?

Current yearPrevious yearGrowGrow %
Making money-$4.3m-$3.5m-$788.5k-18.1%
Net Profit Margin0.0%-34,475.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Benitec (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#393 / 884

Most Revenue
#710 / 884

Most Profit
#394 / 884

Most Efficient
#323 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Benitec?

Welcome investor! Benitec's management wants to use your money to grow the business. In return you get a share of Benitec.

First you should know what it really means to hold a share of Benitec. And how you can make/lose money.

Speculation

The Price per Share of Benitec is $13.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Benitec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Benitec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.66. Based on the TTM, the Book Value Change Per Share is $0.34 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Benitec.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-1.2%-0.15-1.1%-0.14-1.0%-0.14-1.0%-0.12-0.9%-0.10-0.8%
Usd Book Value Change Per Share-0.24-1.8%0.342.6%0.040.3%0.120.9%0.070.5%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.24-1.8%0.342.6%0.040.3%0.120.9%0.070.5%0.030.2%
Usd Price Per Share13.01-10.46-2.94-4.62-4.53-3.69-
Price to Earnings Ratio-20.42--17.62--5.64--8.07--9.97--19.62-
Price-to-Total Gains Ratio-54.19-4.54--17.08--5.17--20.74--19.21-
Price to Book Ratio7.83-6.52-19.78-10.40-12.75-15.81-
Price-to-Total Gains Ratio-54.19-4.54--17.08--5.17--20.74--19.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.17
Number of shares75
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.340.07
Usd Total Gains Per Share0.340.07
Gains per Quarter (75 shares)25.765.07
Gains per Year (75 shares)103.0320.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101039302010
2020619604130
3030929906150
4041240208170
50515505010190
606186080122110
707217110142130
808248140162150
909279170183170
100103010200203190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%5.035.00.012.5%7.044.00.013.7%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%7.013.00.035.0%14.025.01.035.0%17.025.09.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.051.00.0%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%7.013.00.035.0%14.025.01.035.0%17.025.09.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Benitec Biopharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2400.343-170%0.042-665%0.123-296%0.068-455%0.026-1010%
Book Value Per Share--1.6621.589+5%0.310+436%0.698+138%0.541+207%0.451+268%
Current Ratio--14.80416.447-10%3.640+307%7.890+88%8.533+73%11.387+30%
Debt To Asset Ratio--0.0730.068+6%0.410-82%0.275-74%0.223-67%0.151-52%
Debt To Equity Ratio--0.0780.074+6%5.499-99%2.056-96%1.305-94%0.696-89%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--565252469.130360673198.983+57%84357146.725+570%153876822.403+267%141213849.377+300%111168002.809+408%
Eps---0.159-0.147-8%-0.136-15%-0.137-14%-0.119-25%-0.101-37%
Ev To Ebitda Ratio---21.099-17.917-15%-6.242-70%-8.478-60%-10.713-49%-5.445-74%
Free Cash Flow Per Share---0.053-0.111+110%-0.128+143%-0.119+126%-0.105+100%-0.082+55%
Free Cash Flow To Equity Per Share--0.4310.509-15%0.046+832%0.179+140%0.154+179%0.071+503%
Gross Profit Margin--1.0001.0040%1.005-1%1.0030%1.0020%0.985+2%
Intrinsic Value_10Y_max---0.962----------
Intrinsic Value_10Y_min---4.175----------
Intrinsic Value_1Y_max---0.294----------
Intrinsic Value_1Y_min---0.469----------
Intrinsic Value_3Y_max---0.732----------
Intrinsic Value_3Y_min---1.373----------
Intrinsic Value_5Y_max---0.989----------
Intrinsic Value_5Y_min---2.232----------
Market Cap345719085.000-45%502178883.530314613947.133+60%77046530.025+552%134735197.036+273%126956684.097+296%101002513.031+397%
Net Profit Margin----0%-344.7560%-170.6080%-695.6830%-361.7000%
Operating Margin----0%-344.3040%-171.4850%-696.3270%-363.8500%
Operating Ratio----0%338.417-100%169.978-100%686.173-100%357.617-100%
Pb Ratio7.925+1%7.8296.524+20%19.780-60%10.403-25%12.746-39%15.806-50%
Pe Ratio-20.667-1%-20.416-17.618-14%-5.642-72%-8.068-60%-9.970-51%-19.623-4%
Price Per Share13.170+1%13.01010.455+24%2.935+343%4.623+181%4.530+187%3.695+252%
Price To Free Cash Flow Ratio-62.523-1%-61.763-29.825-52%-5.337-91%-12.063-80%-13.012-79%-13.565-78%
Price To Total Gains Ratio-54.859-1%-54.1934.542-1293%-17.080-68%-5.170-90%-20.735-62%-19.206-65%
Quick Ratio--14.74316.344-10%3.510+320%7.739+90%8.279+78%10.116+46%
Return On Assets---0.089-0.086-3%-0.467+425%-0.362+307%-0.326+267%-0.377+324%
Return On Equity---0.096-0.093-3%-6.038+6198%-2.348+2349%-1.539+1505%-1.005+948%
Total Gains Per Share---0.2400.343-170%0.042-665%0.123-296%0.068-455%0.026-1010%
Usd Book Value--64142518.00046829724.650+37%8132038.000+689%20029937.117+220%15218514.170+321%12359087.062+419%
Usd Book Value Change Per Share---0.2400.343-170%0.042-665%0.123-296%0.068-455%0.026-1010%
Usd Book Value Per Share--1.6621.589+5%0.310+436%0.698+138%0.541+207%0.451+268%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--565252469.130360673198.983+57%84357146.725+570%153876822.403+267%141213849.377+300%111168002.809+408%
Usd Eps---0.159-0.147-8%-0.136-15%-0.137-14%-0.119-25%-0.101-37%
Usd Free Cash Flow---2032680.800-3071044.100+51%-3361799.794+65%-3173705.558+56%-2800095.185+38%-2158702.080+6%
Usd Free Cash Flow Per Share---0.053-0.111+110%-0.128+143%-0.119+126%-0.105+100%-0.082+55%
Usd Free Cash Flow To Equity Per Share--0.4310.509-15%0.046+832%0.179+140%0.154+179%0.071+503%
Usd Market Cap345719085.000-45%502178883.530314613947.133+60%77046530.025+552%134735197.036+273%126956684.097+296%101002513.031+397%
Usd Price Per Share13.170+1%13.01010.455+24%2.935+343%4.623+181%4.530+187%3.695+252%
Usd Profit---6149319.600-4353631.500-29%-3565080.200-42%-3750686.133-39%-3229050.190-47%-2240602.674-64%
Usd Revenue----0%2136.550-100%31664.767-100%22090.021-100%242096.014-100%
Usd Total Gains Per Share---0.2400.343-170%0.042-665%0.123-296%0.068-455%0.026-1010%
 EOD+3 -5MRQTTM+13 -20YOY+23 -123Y+23 -125Y+23 -1210Y+24 -11

3.3 Fundamental Score

Let's check the fundamental score of Benitec Biopharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-20.667
Price to Book Ratio (EOD)Between0-17.925
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than114.743
Current Ratio (MRQ)Greater than114.804
Debt to Asset Ratio (MRQ)Less than10.073
Debt to Equity Ratio (MRQ)Less than10.078
Return on Equity (MRQ)Greater than0.15-0.096
Return on Assets (MRQ)Greater than0.05-0.089
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.770
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Benitec Biopharma Ltd ADR

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.

Fundamental data was last updated by Penke on 2025-06-19 01:20:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Benitec earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Benitec to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-34,475.6%+34,475.6%
TTM-5Y-69,568.3%+69,568.3%
5Y-69,568.3%10Y-36,170.0%-33,398.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--141.4%+141.4%
YOY-34,475.6%-186.1%-34,289.5%
3Y-17,060.8%-248.3%-16,812.5%
5Y-69,568.3%-338.6%-69,229.7%
10Y-36,170.0%-488.9%-35,681.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Benitec is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Benitec to theΒ Biotechnology industry mean.
  • -8.9% Return on Assets means thatΒ Benitec generatedΒ $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -8.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-8.6%-0.2%
TTM-8.6%YOY-46.7%+38.0%
TTM-8.6%5Y-32.6%+24.0%
5Y-32.6%10Y-37.7%+5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.9%-11.5%+2.6%
TTM-8.6%-11.6%+3.0%
YOY-46.7%-11.4%-35.3%
3Y-36.2%-11.8%-24.4%
5Y-32.6%-12.1%-20.5%
10Y-37.7%-13.8%-23.9%
4.3.1.3. Return on Equity

Shows how efficient Benitec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Benitec to theΒ Biotechnology industry mean.
  • -9.6% Return on Equity means Benitec generated $-0.10Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -9.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-9.3%-0.3%
TTM-9.3%YOY-603.8%+594.5%
TTM-9.3%5Y-153.9%+144.6%
5Y-153.9%10Y-100.5%-53.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-13.6%+4.0%
TTM-9.3%-14.9%+5.6%
YOY-603.8%-14.4%-589.4%
3Y-234.8%-17.0%-217.8%
5Y-153.9%-17.9%-136.0%
10Y-100.5%-20.1%-80.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Benitec Biopharma Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Benitec is operatingΒ .

  • Measures how much profit Benitec makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Benitec to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-34,430.4%+34,430.4%
TTM-5Y-69,632.7%+69,632.7%
5Y-69,632.7%10Y-36,385.0%-33,247.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--250.3%+250.3%
YOY-34,430.4%-205.1%-34,225.3%
3Y-17,148.5%-220.2%-16,928.3%
5Y-69,632.7%-342.6%-69,290.1%
10Y-36,385.0%-475.5%-35,909.5%
4.3.2.2. Operating Ratio

Measures how efficient Benitec is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY338.417-338.417
TTM-5Y686.173-686.173
5Y686.17310Y357.617+328.555
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.704-2.704
YOY338.4173.063+335.354
3Y169.9783.576+166.402
5Y686.1734.713+681.460
10Y357.6176.512+351.105
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Benitec Biopharma Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Benitec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 14.80Β means the company has $14.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 14.804. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.447. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.804TTM16.447-1.644
TTM16.447YOY3.640+12.807
TTM16.4475Y8.533+7.914
5Y8.53310Y11.387-2.854
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8043.661+11.143
TTM16.4473.786+12.661
YOY3.6404.121-0.481
3Y7.8904.680+3.210
5Y8.5335.765+2.768
10Y11.3876.150+5.237
4.4.3.2. Quick Ratio

Measures if Benitec is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Benitec to theΒ Biotechnology industry mean.
  • A Quick Ratio of 14.74Β means the company can pay off $14.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 14.743. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 16.344. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.743TTM16.344-1.601
TTM16.344YOY3.510+12.834
TTM16.3445Y8.279+8.065
5Y8.27910Y10.116-1.837
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7432.826+11.917
TTM16.3443.128+13.216
YOY3.5103.782-0.272
3Y7.7394.304+3.435
5Y8.2795.703+2.576
10Y10.1166.454+3.662
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Benitec Biopharma Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BenitecΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Benitec to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07Β means that Benitec assets areΒ financed with 7.3% credit (debt) and the remaining percentage (100% - 7.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.073. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.068. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.073TTM0.068+0.004
TTM0.068YOY0.410-0.341
TTM0.0685Y0.223-0.155
5Y0.22310Y0.151+0.072
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0730.324-0.251
TTM0.0680.347-0.279
YOY0.4100.327+0.083
3Y0.2750.339-0.064
5Y0.2230.349-0.126
10Y0.1510.382-0.231
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Benitec is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Benitec to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 7.8% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.078. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.074. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.078TTM0.074+0.004
TTM0.074YOY5.499-5.425
TTM0.0745Y1.305-1.231
5Y1.30510Y0.696+0.609
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0780.383-0.305
TTM0.0740.436-0.362
YOY5.4990.410+5.089
3Y2.0560.446+1.610
5Y1.3050.460+0.845
10Y0.6960.509+0.187
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Benitec generates.

  • Above 15 is considered overpriced butΒ always compareΒ Benitec to theΒ Biotechnology industry mean.
  • A PE ratio of -20.42 means the investor is paying $-20.42Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -20.667. Based on the earnings, the company is expensive. -2
  • The MRQ is -20.416. Based on the earnings, the company is expensive. -2
  • The TTM is -17.618. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.667MRQ-20.416-0.251
MRQ-20.416TTM-17.618-2.798
TTM-17.618YOY-5.642-11.976
TTM-17.6185Y-9.970-7.648
5Y-9.97010Y-19.623+9.652
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-20.667-2.197-18.470
MRQ-20.416-2.027-18.389
TTM-17.618-2.527-15.091
YOY-5.642-3.733-1.909
3Y-8.068-3.717-4.351
5Y-9.970-6.036-3.934
10Y-19.623-6.649-12.974
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -62.523. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -61.763. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -29.825. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-62.523MRQ-61.763-0.760
MRQ-61.763TTM-29.825-31.938
TTM-29.825YOY-5.337-24.488
TTM-29.8255Y-13.012-16.813
5Y-13.01210Y-13.565+0.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-62.523-3.007-59.516
MRQ-61.763-2.704-59.059
TTM-29.825-3.627-26.198
YOY-5.337-4.334-1.003
3Y-12.063-5.070-6.993
5Y-13.012-8.532-4.480
10Y-13.565-9.305-4.260
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Benitec is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 7.83 means the investor is paying $7.83Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is 7.925. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.829. Based on the equity, the company is overpriced. -1
  • The TTM is 6.524. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.925MRQ7.829+0.096
MRQ7.829TTM6.524+1.305
TTM6.524YOY19.780-13.256
TTM6.5245Y12.746-6.223
5Y12.74610Y15.806-3.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.9251.921+6.004
MRQ7.8291.843+5.986
TTM6.5242.113+4.411
YOY19.7802.467+17.313
3Y10.4032.541+7.862
5Y12.7463.666+9.080
10Y15.8064.311+11.495
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Benitec Biopharma Ltd ADR.

4.8.1. Institutions holding Benitec Biopharma Ltd ADR

Institutions are holding 85.16% of the shares of Benitec Biopharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Suvretta Capital Management, LLC37.62414.768987650691649710.2288
2025-03-31HHG PLC11.11960.0214291895030252311.5624
2025-03-31Franklin Resources Inc10.89780.01072860726-78561-2.6728
2025-03-31Adage Capital Partners Gp LLC7.51420.0475197252400
2025-03-31Nantahala Capital Management, LLC3.19270.433383809500
2025-03-31Vanguard Group Inc1.24580.0001327034270139.0037
2024-12-31Schonfeld Strategic Advisors LLC0.9920.0191260417-12400-4.5452
2025-03-31SILVERARC CAPITAL MANAGEMENT, LLC0.95240.66512500002500000
2025-03-31Geode Capital Management, LLC0.89070.00022338203672418.6325
2025-03-31Susquehanna International Group, LLP0.86130.0005226096201324812.7079
2025-03-31BlackRock Inc0.70260.0001184426106736.1426
2025-03-31Awm Investment Company Inc0.52560.24731379773595035.2358
2025-03-31ExodusPoint Capital Management, LP0.31690.010783198831980
2025-03-31Longaeva Partners L.P.0.30480.589480000800000
2025-03-31Simplify Asset Management Inc.0.29230.0374767353980.5214
2025-03-31Lion Point Capital, LP0.23625.14576200000
2025-03-31MYDA Advisors LLC0.19810.11755200020004
2025-03-31Goldman Sachs Group Inc0.17480.000145883458830
2025-03-31Northern Trust Corp0.17480.000145877767720.0969
2025-03-31The Informed Momentum Company (formerly EAM Investors)0.14980.088539330393300
Total 78.366512.202720571594+1948229+9.5%

4.9.2. Funds holding Benitec Biopharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Franklin Biotechnology Discv A(acc)USD5.77211.86081515199-127000-7.7335
2025-04-30Franklin Biotechnology Discovery A4.64162.3374121845400
2025-03-31HBM Healthcare Investments AG Ord4.53960.7738119166915000014.4
2025-03-31Janus Henderson Hrzn Biotec E2 USD1.67771.157244040300
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.24610.004432710087262.7408
2025-04-30Fidelity Extended Market Index0.44680.0044117276-1121-0.9468
2025-04-30Simplify Health Care ETF0.28780.728675541-1194-1.556
2025-02-28RIM Global Bioscience EUR0.23080.73616059900
2025-03-31Extended Equity Market Fund K0.16750.004343982887525.2799
2025-04-30IMC US Ultra Micro Cap0.16540.67674342200
2025-04-30Fidelity Total Market Index0.15170.00053981700
2025-04-30Fidelity Series Total Market Index0.11490.00053015700
2025-03-31MEDICAL BioHealth EUR Acc0.09820.053625765257650
2025-03-31NT Ext Equity Mkt Idx Fd - L0.0970.004225457622032.3335
2025-03-31Northern Trust Extended Eq Market Idx0.0970.004325457622032.3335
2025-04-30Spartan Extended Market Index Pool F0.09140.00442399511214.9008
2025-03-31Pleiades Small Cap Equity A0.08270.030421711217110
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.07410.00421945914578.0935
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05770.0042151488796.1602
2025-04-30Spartan Total Market Index Pool G0.05420.00051423800
Total 20.09438.39055274849+101659+1.9%

5.3. Insider Transactions

Insiders are holding 3.115% of the shares of Benitec Biopharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-26Suvretta Capital Management, LBUY90000013
2024-12-23Suvretta Capital Management, LBUY2750210.98
2024-12-03Suvretta Capital Management, LBUY420009.6
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets105,209
Total Liabilities7,639
Total Stockholder Equity97,570
 As reported
Total Liabilities 7,639
Total Stockholder Equity+ 97,570
Total Assets = 105,209

Assets

Total Assets105,209
Total Current Assets104,010
Long-term Assets1,199
Total Current Assets
Cash And Cash Equivalents 103,583
Net Receivables 3
Other Current Assets 427
Total Current Assets  (as reported)104,010
Total Current Assets  (calculated)104,013
+/- 3
Long-term Assets
Property Plant Equipment 1,109
Long-term Assets Other 90
Long-term Assets  (as reported)1,199
Long-term Assets  (calculated)1,199
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,026
Long-term Liabilities613
Total Stockholder Equity97,570
Total Current Liabilities
Short-term Debt 346
Accounts payable 433
Other Current Liabilities 6,680
Total Current Liabilities  (as reported)7,026
Total Current Liabilities  (calculated)7,459
+/- 433
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt613
Long-term Liabilities  (as reported)613
Long-term Liabilities  (calculated)613
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -212,029
Accumulated Other Comprehensive Income -716
Other Stockholders Equity 310,313
Total Stockholder Equity (as reported)97,570
Total Stockholder Equity (calculated)97,570
+/-0
Other
Capital Stock2
Cash and Short Term Investments 103,583
Common Stock Shares Outstanding 38,599
Liabilities and Stockholders Equity 105,209
Net Debt -102,624
Net Invested Capital 97,570
Net Working Capital 96,984
Property Plant and Equipment Gross 2,565
Short Long Term Debt Total 959



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
0
0
1,605
0
0
0
24,027
0
24,819
0
19,574
0
20,596
20,726
14,853
15,785
14,362
19,243
17,418
16,092
13,848
11,447
15,675
21,862
21,316
646
19,207
308
16,306
13,580
11,587
8,916
15,512
13,428
21,379
17,836
14,014
10,064
5,973
18,115
11,905
8,220
4,464
27,053
21,353
14,999
52,210
68,774
79,068
105,209
105,20979,06868,77452,21014,99921,35327,0534,4648,22011,90518,1155,97310,06414,01417,83621,37913,42815,5128,91611,58713,58016,30630819,20764621,31621,86215,67511,44713,84816,09217,41819,24314,36215,78514,85320,72620,596019,574024,819024,0270001,605000
   > Total Current Assets 
0
0
0
0
0
0
0
23,598
0
24,477
0
19,224
0
20,243
20,269
14,476
15,415
13,945
18,846
17,030
15,710
13,400
11,048
15,349
21,597
21,057
630
18,729
21,920
15,346
12,728
10,809
8,056
14,383
12,407
20,608
16,372
12,672
8,841
4,820
17,081
10,975
7,395
3,729
26,412
20,796
14,366
51,674
68,335
78,713
104,010
104,01078,71368,33551,67414,36620,79626,4123,7297,39510,97517,0814,8208,84112,67216,37220,60812,40714,3838,05610,80912,72815,34621,92018,72963021,05721,59715,34911,04813,40015,71017,03018,84613,94515,41514,47620,26920,243019,224024,477023,5980000000
       Cash And Cash Equivalents 
0
0
0
1,455
0
0
0
20,512
0
21,948
0
16,711
0
16,574
15,223
13,614
10,216
8,840
15,007
13,352
11,532
8,011
8,085
11,816
16,750
16,332
528
15,695
260
13,762
11,400
9,801
7,450
14,010
11,988
19,769
15,727
12,329
8,630
4,062
16,534
10,537
6,551
2,477
25,864
20,374
14,156
50,866
67,841
78,283
103,583
103,58378,28367,84150,86614,15620,37425,8642,4776,55110,53716,5344,0628,63012,32915,72719,76911,98814,0107,4509,80111,40013,76226015,69552816,33216,75011,8168,0858,01111,53213,35215,0078,84010,21613,61415,22316,574016,711021,948020,5120001,455000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,456
0
21
0
72
77
77
78
55
33
22
3
3
0
127
0
23
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
0
0
0
00063000000000000000012301270332233557877777202101,4560000000000000
       Net Receivables 
0
0
0
0
0
0
0
116
0
60
0
189
0
28
25
730
5,041
4,779
3,544
3,386
3,979
4,873
2,429
3,126
4,278
4,171
85
2,536
1,326
928
818
59
18
21
10
25
3
5
5
3
3
68
56
55
53
53
53
229
4
2
3
3242295353535556683355325102118598189281,3262,536854,1714,2783,1262,4294,8733,9793,3863,5444,7795,0417302528018906001160000000
       Other Current Assets 
0
0
0
28
0
0
0
2,969
0
5,486
0
2,325
0
2,184
2,265
132
175
255
436
293
121
920
502
771
72
552
4
501
133
632
509
949
588
352
409
814
642
338
206
755
544
370
788
1,184
482
355
157
516
490
428
427
4274284905161573554821,1847883705447552063386428144093525889495096321335014552727715029201212934362551751322,2652,18402,32505,48602,96900028000
   > Long-term Assets 
0
0
0
0
0
0
0
429
0
342
0
350
0
354
457
378
370
417
397
387
382
449
398
326
0
259
0
478
0
960
852
778
860
1,129
1,021
771
1,464
1,342
1,223
1,153
1,034
930
825
735
641
527
633
536
439
355
1,199
1,1993554395366335276417358259301,0341,1531,2231,3421,4647711,0211,1298607788529600478025903263984493823873974173703784573540350034204290000000
       Property Plant Equipment 
0
0
0
26
0
0
0
429
0
342
0
350
0
354
457
378
325
374
352
342
336
321
273
234
198
193
670
469
1,358
951
843
769
851
910
815
577
1,270
1,156
1,042
993
890
789
695
613
531
451
539
449
358
288
1,109
1,1092883584495394515316136957898909931,0421,1561,2705778159108517698439511,35846967019319823427332133634235237432537845735403500342042900026000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
0
0
0
56
0
67
0
13
0
13
0
9
9
9
219
206
194
194
186
181
160
144
141
0
122
0
30
0
0
0
0
0
00000300122014114416018118619419420621999901301306705600045000000000000000000
> Total Liabilities 
0
0
0
1,018
0
0
0
1,546
0
588
0
1,259
0
730
1,706
786
732
1,005
897
891
1,361
1,420
1,316
1,906
1,553
1,514
89
2,637
20
1,083
1,244
1,349
1,180
887
2,498
1,369
2,361
3,178
2,544
3,091
3,502
2,911
3,507
4,262
4,745
5,883
3,499
4,962
4,594
3,127
7,639
7,6393,1274,5944,9623,4995,8834,7454,2623,5072,9113,5023,0912,5443,1782,3611,3692,4988871,1801,3491,2441,083202,637891,5141,5531,9061,3161,4201,3618918971,0057327861,70673001,259058801,5460001,018000
   > Total Current Liabilities 
0
0
0
1,018
0
0
0
1,546
0
588
0
1,259
0
730
1,693
773
710
985
871
865
1,333
1,390
1,281
1,871
1,547
1,508
89
2,637
1,080
756
981
1,136
1,019
779
2,444
1,369
1,601
2,480
1,909
2,532
3,011
2,489
3,153
3,978
4,534
5,746
3,437
4,924
4,553
3,089
7,026
7,0263,0894,5534,9243,4375,7464,5343,9783,1532,4893,0112,5321,9092,4801,6011,3692,4447791,0191,1369817561,0802,637891,5081,5471,8711,2811,3901,3338658719857107731,69373001,259058801,5460001,018000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
181
187
192
396
406
416
426
388
426
464
504
516
526
269
550
560
572
584
568
211
137
346
34613721156858457256055026952651650446442638842641640639619218718100000000000000000000000000000
       Accounts payable 
0
0
0
256
0
0
0
716
0
197
0
583
0
384
1,391
402
212
467
227
134
541
641
158
426
251
244
49
1,474
142
99
288
282
299
87
1,640
274
323
682
100
422
608
531
635
1,140
1,528
2,619
815
1,351
903
593
433
4335939031,3518152,6191,5281,1406355316084221006823232741,64087299282288991421,474492442514261586415411342274672124021,391384058301970716000256000
       Other Current Liabilities 
0
0
0
762
0
0
0
830
0
391
0
676
0
347
310
371
498
518
644
731
792
749
1,123
1,445
1,155
1,264
34
1,163
453
475
506
662
324
286
388
669
890
1,372
1,345
1,606
1,887
1,432
2,249
2,288
2,446
2,555
2,038
3,427
3,439
2,359
6,680
6,6802,3593,4393,4272,0382,5552,4462,2882,2491,4321,8871,6061,3451,3728906693882863246625064754531,163341,2641,1551,4451,123749792731644518498371310347067603910830000762000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
22
19
25
27
28
30
35
35
0
6
0
0
0
327
263
213
161
108
54
0
760
698
635
559
491
422
354
284
211
137
62
38
41
38
613
61338413862137211284354422491559635698760054108161213263327000603535302827251922131300000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
467
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000046700000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
13
22
20
25
26
29
30
16
14
7
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000271416302926252022131400000000000000
> Total Stockholder Equity
0
0
0
587
0
0
0
22,481
0
24,231
0
18,314
0
19,866
19,020
14,067
15,053
13,358
18,346
16,526
14,731
12,429
10,130
13,769
20,308
19,801
557
16,570
287
15,223
12,336
10,238
7,736
14,625
10,930
20,010
15,475
10,836
7,520
2,882
14,613
8,994
4,713
202
22,308
15,470
11,500
47,248
64,180
75,941
97,570
97,57075,94164,18047,24811,50015,47022,3082024,7138,99414,6132,8827,52010,83615,47520,01010,93014,6257,73610,23812,33615,22328716,57055719,80120,30813,76910,13012,42914,73116,52618,34613,35815,05314,06719,02019,866018,314024,231022,481000587000
   Common Stock
0
0
0
82,127
0
0
0
122,047
0
105,990
0
99,427
0
107,497
113,064
110,256
112,606
108,135
119,035
119,556
122,062
121,353
119,392
120,537
118,543
115,583
164,087
114,917
166,709
116,709
1
1
1
4
5
1
1
1
1
1
3
3
3
0
0
0
0
1
1
2
2
221100003331111154111116,709166,709114,917164,087115,583118,543120,537119,392121,353122,062119,556119,035108,135112,606110,256113,064107,497099,4270105,9900122,04700082,127000
   Retained Earnings Total Equity0000000000000000-126,116-122,2070-116,6360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
1,919
0
1,141
0
1,563
0
1,898
1,772
1,915
1,364
1,079
1,204
1,286
1,429
1,299
1,325
1,096
0
806
0
582
0
319
-2,733
-1,953
-1,775
-1,567
-1,591
-1,455
-1,216
-1,273
-1,506
-1,245
-738
-898
-853
-830
-780
-952
-835
-892
-993
-688
-716
-716-688-993-892-835-952-780-830-853-898-738-1,245-1,506-1,273-1,216-1,455-1,591-1,567-1,775-1,953-2,7333190582080601,0961,3251,2991,4291,2861,2041,0791,3641,9151,7721,89801,56301,14101,9190000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,826
0
138,395
138,632
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000138,632138,3950128,8260000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
517
0
381
0
0
0
0
0
0
2,086
826
0
831
127,327
455
0
128,897
128,827
128,850
138,395
138,632
151,583
151,854
152,093
152,285
152,454
168,768
168,720
168,791
168,921
196,931
197,063
197,255
238,398
260,490
279,302
310,313
310,313279,302260,490238,398197,255197,063196,931168,921168,791168,720168,768152,454152,285152,093151,854151,583138,632138,395128,850128,827128,8970455127,32783108262,086000000381051700000000000000



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue216
Cost of Revenue-108
Gross Profit108108
 
Operating Income (+$)
Gross Profit108
Operating Expense-22,382
Operating Income-22,490-22,274
 
Operating Expense (+$)
Research Development15,609
Selling General Administrative6,712
Selling And Marketing Expenses277
Operating Expense22,38222,598
 
Net Interest Income (+$)
Interest Income-
Interest Expense-904
Other Finance Cost-1,808
Net Interest Income904
 
Pretax Income (+$)
Operating Income-22,490
Net Interest Income904
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-22,370-22,610
EBIT - interestExpense = -23,737
-22,370
-20,847
Interest Expense904
Earnings Before Interest and Taxes (EBIT)-22,833-21,466
Earnings Before Interest and Taxes (EBITDA)-22,490
 
After tax Income (+$)
Income Before Tax-22,370
Tax Provision--
Net Income From Continuing Ops-21,751-22,370
Net Income-21,751
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses22,490
Total Other Income/Expenses Net120-904
 

Technical Analysis of Benitec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Benitec. The general trend of Benitec is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Benitec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Benitec Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Benitec Biopharma Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 12.30 < 13.01 < 16.90.

The bearish price targets are: 10.50 > 9.8 > 9.7.

Know someone who trades $BNTC? Share this with them.πŸ‘‡

Benitec Biopharma Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Benitec Biopharma Ltd ADR. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Benitec Biopharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartBenitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Benitec Biopharma Ltd ADR. The current adx is .

Benitec Biopharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) ChartBenitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Stochastic Oscillator ChartBenitec Biopharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) ChartBenitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartBenitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Williams %R ChartBenitec Biopharma Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Average True Range (ATR) ChartBenitec Biopharma Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) ChartBenitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Money Flow Index (MFI) ChartBenitec Biopharma Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Benitec Biopharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Benitec Biopharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.770
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Benitec with someone you think should read this too:
  • Are you bullish or bearish on Benitec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Benitec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Benitec Biopharma Ltd ADR.

Receive notifications about Benitec Biopharma Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.